Stocktoria
Karyopharm Therapeutics Inc. KPTI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-11-06
Karyopharm Therapeutics Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Oliger Christy J. | director | 2026-05-21 | Grant | 15,508 | — |
| PAKIANATHAN DEEPIKA | director | 2026-05-21 | Grant | 15,508 | — |
| Schor Chen | director | 2026-05-21 | Grant | 15,508 | — |
| Su Zhen | director | 2026-05-21 | Grant | 15,508 | — |
| BOHLIN GAREN G | director | 2026-05-21 | Grant | 15,508 | — |
| Greene Barry E | director | 2026-05-21 | Grant | 15,508 | — |
| Abate Kristin | Chief Accounting Officer | 2026-05-14 | Sell | 53 | $9.50 |
| Poulton Stuart | EVP, Chief Development Officer | 2026-05-14 | Sell | 403 | $9.50 |
Source: SEC EDGAR filings · CIK 0001503802 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.